Import Alert: FDA Working Toward Consistency, Better Decision Making
This article was originally published in The Tan Sheet
Executive Summary
FDA’s broad reorganization might not create for the import staff the same super-specialization coming to other parts of the agency, but a process overhaul appears on its way regardless.
You may also be interested in...
Trusted Trader Program Pairs FDA With Customs To Expedite Imports
The Trusted Trader program would create some incentives to companies willing to ensure their supply chains are secure, but is similar to a program FDA already has in place.
OTC Import Alerts Could Grow Due To PREDICT Requirements
PREDICT eventually will help low-risk importers because data will drive the system to not flag those firms, easing the import process. Firms should work hard to stay off the import alert list, which prompts closer scrutiny and can lead to delays.
FDA’s Authority Looks Safe From Judicial Interference Following Supreme Court Abortion Pill Arguments
The agency's and the pharma industry’s worst fears – that a potential ruling in the mifepristone case might usurp the FDA’s scientific authority and throw the stability of the US drug approval process into question – seem unlikely to materialize as the majority of the Supreme Court justices signal the Alliance for Hippocratic Medicine lacks standing to sue.